Introduction Human Immuno-deficiency Virus (HIV) disease has affected an estimated 40 million people worldwide with 77% of them under antiretroviral therapy (ART) (2023). However, the disease has been found to cause metabolic syndrome with various abnormalities leading to increased cardiovascular disease (CVD) risk. However, this risk of metabolic syndromehas been found to develop in HIV patients even before their exposure to ART, yet the exact pathogenesis behind the subject is unclear. This syndrome in addition to the HIV complicationshas been known to compromise the quality of life of patients. This review was thus conducted to understand the metabolic abnormalities arising after exposure to ART and its level of impact on their quality of life Methods A comprehensive literature review was conducted in research databases like PubMed, Medline, EMBASE, and Cochrane and the search was dated till 2010. The search was performed using MeSH keywords and only published articles were considered for final review. Results Our search provided 19 articles regarding metabolic syndrome developing in HIV patients after ART and its impact on their quality of life. The adverse effects of the treatment were found to be moreamongolder age, women andobese people. The common metabolic syndrome affections were more concerned with the weight of patients, their psychological well-being, and overall health-related quality of life. Conclusion The impact of ART on HIV affected individuals has been multi-dimensional including metabolic abnormalities and coping strategies in terms of improving quality of life needs inclusive rework to provide better outcomes.